Neoplasms, Liver clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
NOLA (NeuWave Observational Liver Ablation) Registry
open to eligible people ages 22 years and up
This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.
Our lead scientists for Neoplasms, Liver research studies include Thomas Le, MD Justin McWilliams, MD.